| Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania E Pisani, AL Nistor, A Hasnida, K Parmaksiz, J Xu, MO Kok Wellcome open research 4, 2019 | 68 | 2019 |
| Global access to quality-assured medical products: the Oxford statement and call to action PN Newton, KC Bond, P Newton, K Bond, V Abiola, K Ade-Abolade, ... The Lancet Global Health 7 (12), e1609-e1611, 2019 | 33 | 2019 |
| A systematic review of pooled procurement of medicines and vaccines: identifying elements of success K Parmaksiz, E Pisani, R Bal, MO Kok Globalization and health 18 (1), 59, 2022 | 21 | 2022 |
| What makes a national pharmaceutical track and trace system succeed? Lessons from Turkey K Parmaksiz, E Pisani, MO Kok Global Health: Science and Practice 8 (3), 431-441, 2020 | 13 | 2020 |
| Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania. Wellcome Open Res … E Pisani, AL Nistor, A Hasnida, K Parmaksiz, J Xu, MO Kok | 7 | |
| Supporting data for: identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China E Pisani, AL Nistor, A Hasnida Indonesia, turkey and Romania, 2019 | 4 | 2019 |
| From promise to practice: a guide to developing pooled procurement mechanisms for medicines and vaccines K Parmaksiz, R Bal, H Van de Bovenkamp, MO Kok Journal of Pharmaceutical Policy and Practice 16 (1), 73, 2023 | 3 | 2023 |
| The effect of diabetes on the quality-of-life in community-dwelling elderly in The Netherlands K Parmaksiz, M Bolkenbaas, S Huijts, G de Wit, C van Werkhoven, ... Value in Health 19 (7), A679-A680, 2016 | 3 | 2016 |
| Does structural form matter? A comparative analysis of pooled procurement mechanisms for health commodities K Parmaksiz, H van de Bovenkamp, R Bal Globalization and Health 19 (1), 90, 2023 | 1 | 2023 |
| The Political Economy of Substandard and Falsified Medicines: An Evidence-Informed Risk-Assessment Framework Based on a Multi-Country Study E Pisani, AL Nistor, A Hasnida, K Parmaksiz, J Xu, MO Kok Available at SSRN 3244911, 2018 | 1 | 2018 |
